Use of 10-hydroxy-10,11-dihydrocarbamazepin e derivatives for the treatment of affective disorders

Details for Australian Patent Application No. 2004226827 (hide)

Owner Novartis AG

Inventors Zechner, Stefanie; Martenyi, Ferenc; Schmutz, Markus

Agent Davies Collison Cave

Pub. Number AU-B-2004226827

PCT Pub. Number WO2004/087168

Priority 60/459,864 02.04.03 US

Filing date 1 April 2004

Wipo publication date 14 October 2004

Acceptance publication date 3 April 2008

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087168 Priority application(s): WO2004/087168

3 April 2008 Application Accepted

  Published as AU-B-2004226827

31 July 2008 Standard Patent Sealed

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226832-An adhesive patch

2004226825-Combinations comprising anti-epileptic drugs for the treatment of neurological disorders